Account Sign in
Register Here
Find
quick buy
quick buy
Quick Cart
Try a free sample!, Click here for more information.
new products
freezer programs
About NEB
NEB tools
request a catalogue
Technical Support
Starting a new lab? Are you a new investigator? Click here for a quote with even greater discounts!
Double Digest & Enzyme Finder on your iPhone. Click here to download the free NEB Tools app  from the iTunes store.

Neuroscience

AMPA Receptor (GluR 2) (D39F2) Rabbit mAb #5306

Item # Description List Price Web Price QTY Buy
5306S AMPA Receptor (GluR 2) (D39F2) Rabbit mAb - 100ul $300.00 $270.00
Applications Reactivity Sensitivity MW (kDa) Source
W H M R Endogenous 100 Rabbit

Applications Key:   W = Western Blotting
Reactivity Key: H = Human  M = Mouse  R = Rat  
Species cross-reactivity is determined by Western blot.

Protocols

Specificity / Sensitivity

AMPA Receptor (GluR 2) (D39F2) Rabbit mAb detects endogenous levels of total GluR 2 protein. The antibody is not predicted to recognize other AMPA receptor subunits (e.g. GluR 1, GluR 3 or GluR 4) based on sequence homology of the antigen.

Source / Purification

Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues near the amino terminus of human GluR 2 protein.

Western Blotting

Western Blotting

Western blot analysis of extracts from mouse and rat brains using AMPA Receptor (GluR 2) (D39F2) Rabbit mAb.

Background

AMPA- (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid), kainite- and NMDA- (N-methyl-D-aspartate) receptors are the three main families of ionotropic glutamate-gated ion channels. AMPA receptors (AMPARs) are comprised of four subunits (GluR 1-4), which assemble as homo- or hetero-tetramers to mediate the majority of fast excitatory transmissions in the CNS. AMPARs are implicated in synapse formation, stabilization and plasticity (1). AMPARs that lack GluR 2 are permeable to calcium, in contrast to GluR 2 containing AMPARs (2). Post-transcriptional modifications (alternative splicing, nuclear RNA editing) and post-translational modifications (glycosylation, phosphorylation) result in a very large number of permutations, fine-tuning the kinetic properties of AMPARs. Activity changes of AMPARs are implicated in a variety of diseases including Alzheimer’s, amyotrophic lateral sclerosis (ALS), stroke and epilepsy (1).

  1. Palmer, C.L. et al. (2005) Pharmacol Rev57, 253 - 77.
  2. Cull-Candy, S. et al. (2006) Curr Opin Neurobiol16, 288 - 97.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products


This product is for in vitro research use only and is not intended for use in humans or animals. This product is not intended for use as therapeutic or in diagnostic procedures.